This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective To test whether elevated blood pressure (BP) relates to gray matter (GM) volume (GMV) changes in young adults who had not previously been diagnosed with hypertension (systolic BP [SBP]/diastolic BP [DBP] ≥140/90 mm Hg).
Methods We associated BP with GMV from structural 3T T1-weighted MRI of 423 healthy adults between 19 and 40 years of age (mean age 27.7 ± 5.3 years, 177 women, SBP/DBP 123.2/73.4 ± 12.2/8.5 mm Hg). Data originated from 4 previously unpublished cross-sectional studies conducted in Leipzig, Germany. We performed voxel-based morphometry on each study separately and combined results in image-based meta-analyses (IBMA) to assess cumulative effects across studies. Resting BP was assigned to 1 of 4 categories: (1) SBP <120 and DBP <80 mm Hg, (2) SBP 120–129 or DBP 80–84 mm Hg, (3) SBP 130–139 or DBP 85–89 mm Hg, (4) SBP ≥140 or DBP ≥90 mm Hg.
Results IBMA yielded the following results: (1) lower regional GMV was correlated with higher peripheral BP; (2) lower GMV was found with higher BP when comparing individuals in subhypertensive categories 3 and 2, respectively, to those in category 1; (3) lower BP-related GMV was found in regions including hippocampus, amygdala, thalamus, frontal, and parietal structures (e.g., precuneus).
Conclusion BP ≥120/80 mm Hg was associated with lower GMV in regions that have previously been related to GM decline in older individuals with manifest hypertension. Our study shows that BP-associated GM alterations emerge continuously across the range of BP and earlier in adulthood than previously assumed. This suggests that treating hypertension or maintaining lower BP in early adulthood might be essential for preventing the pathophysiologic cascade of asymptomatic cerebrovascular disease to symptomatic end-organ damage, such as stroke or dementia.
Glossary
- AD=
- Alzheimer disease;
- ANOVA=
- analysis of variance;
- BMI=
- body mass index;
- BP=
- blood pressure;
- CSFV=
- cerebrospinal fluid volume;
- CVD=
- cerebrovascular disease;
- DBP=
- diastolic blood pressure;
- FA=
- flip angle;
- FLAIR=
- fluid-attenuated inversion recovery;
- FOV=
- field of view;
- FWE=
- family-wise error;
- GM=
- gray matter;
- GMV=
- gray matter volume;
- HTN=
- hypertension;
- IBMA=
- image-based meta-analyses;
- LIFE Study=
- Leipzig Research Centre for Civilization Diseases Study;
- ROI=
- region of interest;
- SBP=
- systolic blood pressure;
- SDM=
- seed-based d mapping;
- TE=
- echo time;
- TI=
- inversion time;
- TIV=
- total intracranial volume;
- TR=
- repetition time;
- VBM=
- voxel-based morphometry;
- WM=
- white matter;
- WMH=
- white matter hyperintensities;
- WMV=
- white matter volume
Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
- Received January 9, 2018.
- Accepted in final form October 15, 2018.
- © 2019 American Academy of Neurology
Disputes & Debates: Rapid online correspondence
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within the last 8 weeks.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.